BALCHEM CORPORATION— Sankey Diagram
Annual mode · period ending 2025-12-31 · SEC EDGAR
FY2025 - Q4(Oct 25 · Nov 25 · Dec 25)
Total Assets
$1.69B
↑+7.0% +$111Mvs FY2024
Total Liabilities
$429M
↑+0.8% +$3Mvs FY2024
Equity
$1.26B
↑+9.3% +$108Mvs FY2024
Cash
$75M
↑+50.6% +$25Mvs FY2024
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
| Line item | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $1.69B | $1.58B |
| Current Assets | $366M | $314M |
| Cash | $75M | $50M |
| ST Investments | $0 | $0 |
| Receivables | $144M | $120M |
| Inventory | $131M | $131M |
| Other Current | $16M | $14M |
| Non-Current Assets | $1.32B | $1.26B |
| PPE | $307M | $282M |
| Goodwill | $816M | $780M |
| Intangibles | $133M | $132M |
| Investments | $0 | $0 |
| Other Non-Current | $65M | $67M |
| Total Liab+Eq | $1.69B | $1.58B |
| Current Liab. | $176M | $158M |
| Accounts Payable | $0 | $0 |
| Short-Term Debt | $0 | $0 |
| Deferred Revenue | $0 | $0 |
| Other CL | $176M | $158M |
| Non-Current Liab. | $252M | $268M |
| Long-Term Debt | $0 | $0 |
| Other LT Liab. | $252M | $268M |
| Equity | $1.26B | $1.15B |
| Retained Earnings | $1.12B | $997M |
| Other Equity | $136M | $152M |
QuarterCharts · SEC EDGAR data · BCPC · Comparing FY2025 vs FY2024